Skip to main content

Table 3 Number of visits to ERs, GPs and specialists, number of tests, and avoidable healthcare resource consumption in the 12 months before enrolment by risk level and LDL-C goal achievement

From: Healthcare resource utilization in patients on lipid-lowering therapies outside Western Europe and North America: findings of the cross-sectional observational International ChoLesterol management Practice Study (ICLPS)

 

Risk Level

LDL-C Goal Achieved

All

(N = 9049)

Low Risk

(n = 70)

Moderate Risk

(n = 411)

High Risk

(n = 2621)

Very-High Risk

(n = 4842)

Risk Non-Assessable

(n = 1105)

Yes

(n = 3140)

No

(n = 4734)

At least one visit to the ER in the last 12 months, n (%)

n = 68

9 (13.2)

n = 395

30 (7.6)

n = 2440

194 (8.0)

n = 4649

865 (18.6)

n = 1053

89 (8.5)

n = 2955

353 (11.9)

n = 4529

736 (16.3)

n = 8605

1187 (13.8)

Number of visits to:

An ER

n = 52

n = 319

n = 1863

n = 3773

n = 820

n = 2355

n = 3600

n = 6827

 Mean ± SD

0.23 ± 0.55

0.21 ± 0.82

0.19 ± 0.75

0.42 ± 1.32

0.19 ± 0.78

0.26 ± 0.92

0.39 ± 1.28

0.32 ± 1.11

 Median (IQR)

0.0

(0.0–0.0)

0.0

(0.0–0.0)

0.0

(0.0–0.0)

0.0

(0.0–0.0)

0.0

(0.0–0.0)

0.0

(0.0–0.0)

0.0

(0.0–0.0)

0.0

(0.0–0.0)

A GP

n = 57

n = 330

n = 2017

n = 3747

n = 902

n = 2438

n = 3656

n = 7053

 Mean ± SD

2.54 ± 2.40

2.78 ± 3.89

2.91 ± 3.34

2.66 ± 4.30

2.44 ± 3.06

2.66 ± 3.69

2.81 ± 4.17

2.71 ± 3.87

 Median (IQR)

2.0

(0.0–4.0)

2.0

(0.0–4.0)

2.0

(0.0–4.0)

1.0

(0.0–4.0)

2.0

(0.0–3.0)

2.0

(0.0–4.0)

2.0

(0.0–4.0)

2.0

(0.0–4.0)

A CV specialist

n = 55

n = 345

n = 1992

n = 4402

n = 870

n = 2630

n = 4109

n = 7664

 Mean ± SD

1.05 ± 1.63

1.41 ± 1.71

0.99 ± 1.53

2.37 ± 2.32

1.30 ± 1.77

1.92 ± 2.30

1.90 ± 2.10

1.83 ± 2.14

 Median (IQR)

0.0

(0.0–2.0)

1.0

(0.0–2.0)

0.0

(0.0–2.0)

2.0

(1.0–3.0)

1.0

(0.0–2.0)

1.0

(0.0–3.0)

2.0

(0.0–3.0)

1.0

(0.0–3.0)

Another specialist

n = 58

n = 337

n = 1991

n = 3845

n = 800

n = 2441

n = 3732

n = 7031

 Mean ± SD

2.81 ± 4.59

2.12 ± 3.78

2.15 ± 3.47

2.91 ± 4.93

1.38 ± 2.44

2.74 ± 4.72

2.55 ± 4.29

2.49 ± 4.30

 Median (IQR)

2.0

(0.0–3.0)

1.0

(0.0–3.0)

1.0

(0.0–3.0)

1.0

(0.0–4.0)

0.0

(0.0–2.0)

1.0

(0.0–3.0)

1.0

(0.0–3.0)

1.0

(0.0–3.0)

Number of tests

ECG

n = 62

n = 352

n = 2125

n = 4379

n = 927

n = 2678

n = 4178

n = 7845

 Mean ± SD

0.92 ± 0.84

0.88 ± 0.95

1.08 ± 1.21

1.98 ± 2.62

1.08 ± 1.15

1.58 ± 2.52

1.69 ± 2.07

1.57 ± 2.16

 Median (IQR)

1.0

(0.0–1.0)

1.0

(0.0–1.0)

1.0

(0.0–1.0)

1.0

(0.0–3.0)

1.0

(0.0–1.0)

1.0

(0.0–2.0)

1.0

(1.0–2.0)

1.0

(0.0–2.0)

Echocardiography

n = 55

n = 334

n = 1949

n = 4218

n = 848

n = 2549

n = 3952

n = 7404

 Mean ± SD

0.29 ± 0.46

0.34 ± 0.53

0.29 ± 0.56

0.75 ± 0.91

0.34 ± 0.60

0.53 ± 0.79

0.63 ± 0.85

0.56 ± 0.81

 Median (IQR)

0.0

(0.0–1.0)

0.0

(0.0–1.0)

0.0

(0.0–0.0)

1.0

(0.0–1.0)

0.0

(0.0–1.0)

0.0

(0.0–1.0)

0.0

(0.0–1.0)

0.0

(0.0–1.0)

Stress ECG

n = 54

n = 323

n = 1914

n = 3857

n = 827

n = 2396

n = 3698

n = 6975

 Mean ± SD

0.15 ± 0.36

0.18 ± 0.40

0.10 ± 0.32

0.22 ± 0.51

0.15 ± 0.39

0.17 ± 0.44

0.19 ± 0.47

0.18 ± 0.45

 Median (IQR)

0.0

(0.0–0.0)

0.0

(0.0–0.0)

0.0

(0.0–0.0)

0.0

(0.0–0.0)

0.0

(0.0–0.0)

0.0

(0.0–0.0)

0.0

(0.0–0.0)

0.0

(0.0–0.0)

Lab test including cholesterol

n = 68

n = 403

n = 2545

n = 4695

n = 1062

n = 3053

n = 4590

n = 8773

 Mean ± SD

2.41 ± 1.35

2.26 ± 1.18

2.06 ± 1.29

2.16 ± 1.62

1.86 ± 1.03

2.13 ± 1.58

2.14 ± 1.44

2.10 ± 1.45

 Median (IQR)

2.0

(2.0–3.0)

2.0

(1.0–3.0)

2.0

(1.0–2.0)

2.0

(1.0–3.0)

2.0

(1.0–2.0)

2.0

(1.0–3.0)

2.0

(1.0–3.0)

2.0

(1.0–3.0)

Avoidable healthcare consumptionan (%)

n = 68

9 (13.2)

n = 405

31 (7.7)

n = 2584

200 (7.7)

n = 4799

1332 (27.8)

n = 1073

94 (8.8)

n = 3099

515 (16.6)

n = 4689 1048 (22.4)

n = 8929 1666 (18.7)

  1. aDefined as at least one hospitalization for CV reasons or at least one visit to the ER
  2. CV, cardiovascular; ECG, electrocardiogram; ER, emergency room; GP, general practitioner; IQR, interquartile range; LDL-C, low-density lipoprotein cholesterol; n, number of patients in the sample population; SD, standard deviation